Contact
searchSearch
HMP Global
Login

news

Conference Insider
Dr Shah Highlights Benefits of Pomalidomide in Patients With MM
03/25/2022
Nina Shah, MD, presents pomalidomide as a superior treatment versus carfilzomib for patients with MM during the virtual Great Debates & Updates in Hematologic Malignancies.
Nina Shah, MD, presents pomalidomide as a superior treatment versus carfilzomib for patients with MM during the virtual Great Debates & Updates in Hematologic Malignancies.
Nina Shah, MD, presents...
03/25/2022
Oncology
Conference Insider
Dr Martin Discusses How to Approach MCL
03/23/2022
Peter Martin, MD, discusses how to approach MCL, including what’s been learned so far and what’s to be expected, at the virtual Great Debates & Updates in Hematologic Malignancies.
Peter Martin, MD, discusses how to approach MCL, including what’s been learned so far and what’s to be expected, at the virtual Great Debates & Updates in Hematologic Malignancies.
Peter Martin, MD, discusses how...
03/23/2022
Oncology
Conference Insider
Dr Leonard Highlights Crucial New Data, Practice Changing Therapies in DLBCL
03/23/2022
John Leonard, MD, presents novel data with CAR-T therapies in upfront, second line DLBCL during the virtual Great Debates & Updates in Hematologic Malignancies.
John Leonard, MD, presents novel data with CAR-T therapies in upfront, second line DLBCL during the virtual Great Debates & Updates in Hematologic Malignancies.
John Leonard, MD, presents novel...
03/23/2022
Oncology
Conference Insider
Naveen Pemmaraju, MD, Provides an Overview of Novel Therapies for MPNs
03/01/2021
During the virtual Great Debates & Updates in Hematologic Malignancies, Dr Pemmaraju discussed new therapies for myeloproliferative neoplasms (MPNs) with a focus on CMML.
During the virtual Great Debates & Updates in Hematologic Malignancies, Dr Pemmaraju discussed new therapies for myeloproliferative neoplasms (MPNs) with a focus on CMML.
During the virtual Great Debates...
03/01/2021
Oncology
News
Michael Mauro, MD, Talks ELN/NCCN Recommendations for Patients With CML
07/18/2020
At the virtual Great Debates & Updates in Hematologic Malignancies, Michael Mauro, MD, presented on practical approaches for monitoring patients with CML as per NCCN and ELN recommendations.
At the virtual Great Debates & Updates in Hematologic Malignancies, Michael Mauro, MD, presented on practical approaches for monitoring patients with CML as per NCCN and ELN recommendations.
At the virtual Great Debates &...
07/18/2020
Oncology
News
Update on Upfront and Maintenance Therapy in Follicular Lymphoma
03/23/2019
John P. Leonard, MD, presented an update on upfront and maintenance therapy in follicular lymphoma at the 2019 Great Debates and Updates in Hematologic Malignancies meeting.
John P. Leonard, MD, presented an update on upfront and maintenance therapy in follicular lymphoma at the 2019 Great Debates and Updates in Hematologic Malignancies meeting.
John P. Leonard, MD, presented...
03/23/2019
Oncology
News
Three-Drug Regimens Considered Standard in Multiple Myeloma Salvage Therapy
04/26/2018
Suzanne Lentzsch, MD, PhD, presented data that three drug regimens should be considered standard for myeloma salvage therapy.
Suzanne Lentzsch, MD, PhD, presented data that three drug regimens should be considered standard for myeloma salvage therapy.
Suzanne Lentzsch, MD, PhD,...
04/26/2018
Oncology

About

At Great Debates and Updates in Hematologic Malignancies, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology.

Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.

Platinum Sponsors

johnson & johnson

 

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use